First study of safety and tolerability of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in patients with alcohol use disorder: preliminary data on the first four participants

We present the preliminary data in an ongoing open-label safety and tolerability proof of concept study exploring the potential role for 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in treating patients with alcohol use disorder. At this stage, seven participants have completed th...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMJ Case Rep
Huvudupphovsmän: Sessa, Ben, Sakal, Chloe, O’Brien, Steve, Nutt, David
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Publishing Group 2019
Ämnen:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6663239/
https://ncbi.nlm.nih.gov/pubmed/31308191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-230109
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk